Back

Activin signalling inhibitors

30 August 2025 (16:15 - 16:30)
Organised by: Logo
Congress Presentation Part of: Paradigm change in pulmonary hypertension: from bench to bedside Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Vallerie McLaughlin

University of Michigan, Ann Arbor (United States of America)

3 More presentations in this session

Presentation thumbnail
Tyrosine kinase inhibitors
Professor S. Rosenkranz (Cologne, DE)
Slides Video
Presentation thumbnail
Precision medicine in pulmonary arterial hypertension: the right time?
Doctor A. Boucly (Le Kremlin Bicetre, FR)
Slides Video
Presentation thumbnail
Pulmonary artery denervation
Doctor S. Chen (Nanjing, CN)
Slides Video

Access the full session

Session thumbnail
Paradigm change in pulmonary hypertension: from bench to bedside
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 16:15 CET
You may be interested in
thumbnail
Congress Session
Paradigm change in pulmonary hypertension: from bench to bedside
thumbnail
Congress Session
Molecular approaches to the treatment of pulmonary hypertension
thumbnail
Congress Session
A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources